Akdogan, O. Et Al. 2019. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.9, no.1 , 29-33.

Akdogan, O., Yucel, A., Sargin, Z. G., Sonmez, C., Yilmaz, G. E., & Ozenirler, S., (2019). Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.9, no.1, 29-33.

Akdogan, Ozlem Et Al. "Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker," JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.9, no.1, 29-33, 2019

Akdogan, Ozlem Et Al. "Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker." JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.9, no.1, pp.29-33, 2019

Akdogan, O. Et Al. (2019) . "Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker." JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.9, no.1, pp.29-33.

@article{article, author={Ozlem Akdogan Et Al. }, title={Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker}, journal={JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY}, year=2019, pages={29-33} }